Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q415051> ?p ?o }
Showing triples 1 to 61 of
61
with 100 triples per page.
- Q415051 subject Q52361.
- Q415051 subject Q7145105.
- Q415051 subject Q8220082.
- Q415051 subject Q8236104.
- Q415051 subject Q8965786.
- Q415051 subject Q9546190.
- Q415051 abstract "Midodrine (brand names Amatine, ProAmatine, Gutron) is a vasopressor/antihypotensive agent. Midodrine was approved in the United States by the Food and Drug Administration (FDA) in 1996 for the treatment of dysautonomia and orthostatic hypotension. In August 2010, the FDA proposed withdrawing this approval because the manufacturer, Shire plc, has failed to complete required studies after the medicine reached the market.In September 2010, the FDA reversed its decision to remove midodrine from the market and has allowed it to remain available to patients while Shire plc collects further data regarding the efficacy and safety of the drug. Shire plc announced on September 27, 2011 that it was continuing the process to work with the FDA towards a final approval of the drug.".
- Q415051 atcPrefix "C01".
- Q415051 atcSuffix "CA17".
- Q415051 casNumber "133163-28-7".
- Q415051 chEBI "6933".
- Q415051 drugbank "DB00211".
- Q415051 fdaUniiCode "6YE7PBM15H".
- Q415051 iupacName "(RS)- N-[2-(2,5-Dimethoxyphenyl)-2-hydroxyethyl]glycinamide".
- Q415051 pubchem "4195".
- Q415051 thumbnail Midodrine.svg?width=300.
- Q415051 wikiPageExternalLink midodrine.html.
- Q415051 wikiPageWikiLink Q147778.
- Q415051 wikiPageWikiLink Q14982.
- Q415051 wikiPageWikiLink Q202301.
- Q415051 wikiPageWikiLink Q204711.
- Q415051 wikiPageWikiLink Q221694.
- Q415051 wikiPageWikiLink Q247131.
- Q415051 wikiPageWikiLink Q2511166.
- Q415051 wikiPageWikiLink Q288060.
- Q415051 wikiPageWikiLink Q389934.
- Q415051 wikiPageWikiLink Q407595.
- Q415051 wikiPageWikiLink Q410568.
- Q415051 wikiPageWikiLink Q411258.
- Q415051 wikiPageWikiLink Q419935.
- Q415051 wikiPageWikiLink Q4545697.
- Q415051 wikiPageWikiLink Q467717.
- Q415051 wikiPageWikiLink Q47273.
- Q415051 wikiPageWikiLink Q52361.
- Q415051 wikiPageWikiLink Q603741.
- Q415051 wikiPageWikiLink Q620639.
- Q415051 wikiPageWikiLink Q6558704.
- Q415051 wikiPageWikiLink Q684782.
- Q415051 wikiPageWikiLink Q7104966.
- Q415051 wikiPageWikiLink Q7145105.
- Q415051 wikiPageWikiLink Q8220082.
- Q415051 wikiPageWikiLink Q8236104.
- Q415051 wikiPageWikiLink Q8965786.
- Q415051 wikiPageWikiLink Q905049.
- Q415051 wikiPageWikiLink Q9546190.
- Q415051 atcPrefix "1.0".
- Q415051 atcSuffix "CA17".
- Q415051 casNumber "133163".
- Q415051 chebi "6933".
- Q415051 drugbank "DB00211".
- Q415051 iupacName "- N-[2--2-hydroxyethyl]glycinamide".
- Q415051 pubchem "4195".
- Q415051 unii "6".
- Q415051 type ChemicalSubstance.
- Q415051 type Drug.
- Q415051 type ChemicalObject.
- Q415051 type Thing.
- Q415051 type Q8386.
- Q415051 comment "Midodrine (brand names Amatine, ProAmatine, Gutron) is a vasopressor/antihypotensive agent. Midodrine was approved in the United States by the Food and Drug Administration (FDA) in 1996 for the treatment of dysautonomia and orthostatic hypotension.".
- Q415051 label "Midodrine".
- Q415051 depiction Midodrine.svg.
